As a result of this educational regularly scheduled series, learners as members of the healthcare team will be able to:

  • Examine the clinical signs and symptoms of histoplasmosis and its various classifications.
  • Identify the benefits and toxicities associated with first-line therapy for severe histoplasmosis.
  • Summarize the importance of therapeutic drug monitoring in long-term therapy for chronic histoplasmosis.
Session date: 
09/19/2023 - 1:00pm to 2:00pm CDT
In-person and Virtually
Will be determined by room availability
600 Highland Ave
Madison, WI 53705
United States
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 ACPE Contact Hours - Pharmacist Technician
  • 1.00 University of Wisconsin–Madison Continuing Education Hours

Please login or register to take this course.
Discloser List CME Internal Report
Jared Walz